Emend Intravenous and Plasma-Lyte 56 and Dextrose
Determining the interaction of Emend Intravenous and Plasma-Lyte 56 and Dextrose and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fosaprepitant
Brand name: Emend for Injection
Synonyms: Fosaprepitant
Generic Name: lvp solution with potassium
Brand name:
Synonyms: Dextrose and Electrolyte No 48
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emend Intravenous-Platinol
- Emend Intravenous-Platinol-AQ
- Emend Intravenous-Plavix
- Emend Intravenous-Plazomicin
- Emend Intravenous-Plazomicin Intravenous
- Emend Intravenous-Plazomicin Sulfate
- Plasma-Lyte 56 and Dextrose-Emflaza
- Plasma-Lyte 56 and Dextrose-Emflaza (Deflazacort Oral Suspension)
- Plasma-Lyte 56 and Dextrose-Emflaza (Deflazacort Tablets)
- Plasma-Lyte 56 and Dextrose-Emicizumab
- Plasma-Lyte 56 and Dextrose-Emicizumab-kxwh
- Plasma-Lyte 56 and Dextrose-Emicizumab-kxwh Subcutaneous